Elekta AB (publ)

Stockholm Stock Exchange EKTA-B.ST

Elekta AB (publ) Market Capitalization on January 14, 2025: USD 2.06 B

Elekta AB (publ) Market Capitalization is USD 2.06 B on January 14, 2025, a -28.25% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Elekta AB (publ) 52-week high Market Capitalization is USD 3.12 B on May 28, 2024, which is 51.69% above the current Market Capitalization.
  • Elekta AB (publ) 52-week low Market Capitalization is USD 2.06 B on January 14, 2025, which is 0.00% below the current Market Capitalization.
  • Elekta AB (publ) average Market Capitalization for the last 52 weeks is USD 2.54 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Stockholm Stock Exchange: EKTA-B.ST

Elekta AB (publ)

CEO Mr. Gustaf Salford
IPO Date Jan. 3, 2000
Location Sweden
Headquarters Kungstensgatan 18
Employees 4,566
Sector Health Care
Industries
Description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Similar companies

ASSA-B.ST

ASSA ABLOY AB (publ)

USD 28.05

0.01%

SECU-B.ST

Securitas AB (publ)

USD 11.89

-0.26%

SKF-B.ST

AB SKF (publ)

USD 18.74

0.97%

HUSQ-B.ST

Husqvarna AB (publ)

USD 5.03

1.76%

GETI-B.ST

Getinge AB (publ)

USD 16.63

0.49%

StockViz Staff

January 15, 2025

Any question? Send us an email